MytosCell Manufacturing company
Mytos builds fully-automated robotic platforms for manufacturing human cells, specifically stem cell-derived therapies. They operate as a CDMO, aiming to scale regenerative medicine from clinical development to commercial production, enabling low-cost access for millions of patients.
- Category
- Cell Manufacturing
- Stage
- Series A
- Employees
- 42
- HQ
- London, United Kingdom
- Founded
- 2016
- Funding
- $30M